Foghorn Therapeutics Inc.
FHTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001822462
No open-market purchases or sales by Foghorn Therapeutics Inc. insiders were filed in the last 90 days; 102 institutions reported holding it in 13F filings for Q2 2026, worth $219.2M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Foghorn Therapeutics Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 105 | 3 | 102 | 0 |
| Shares | 44.4M | 11.4K | 44.9M | +494.3K (+1.1%) |
| Value | $212.4M | $54.7K | $219.2M | +$6.84M (+3.2%) |
3 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (14)
Institutions that held Foghorn Therapeutics Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Palumbo Wealth Management LLC | 91,739 | $447.7K | 0.09% |
| Lynx1 Capital Management LP | 61,588 | $300.5K | 0.03% |
| Silverarc Capital Management, LLC | 45,975 | $224.4K | 0.02% |
| Gsa Capital Partners LLP | 29,506 | $144.0K | 0.01% |
| EntryPoint Capital, LLC | 15,483 | $75.6K | 0.02% |
| Two Sigma Investments, LP | 12,445 | $60.7K | 0.00% |
| Evelyn Partners Group Ltd | 7,100 | $34.6K | 0.00% |
| SRS Capital Advisors, Inc. | 1,136 | $5.54K | 0.00% |
| International Assets Investment Management, LLC | 1,000 | $5.01K | 0.00% |
| TD Waterhouse Canada Inc. | 1,000 | $5.01K | 0.00% |
| Bare Financial Services, Inc | 247 | $1.21K | 0.00% |
| Caitong International Asset Management Co., Ltd | 17 | $83 | 0.00% |
| Clearstead Advisors, LLC | 9 | $44 | 0.00% |
| SJS Investment Consulting Inc. | 9 | $44 | 0.00% |
Sold out (14)
Institutions that held Foghorn Therapeutics Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Sio Capital Management, LLC | 122,889 | $587.4K |
| Walleye Capital LLC | 34,445 | $164.6K |
| Trexquant Investment LP | 30,111 | $143.9K |
| Point72 Asset Management, L.P. | 27,646 | $132.1K |
| Algert Global LLC | 13,928 | $66.6K |
| Kingswood Wealth Advisors, LLC | 12,500 | $59.8K |
| Sphera Funds Management Ltd. | 12,224 | $58.4K |
| Prudential Financial Inc | 12,205 | $58.3K |
| Susquehanna International Group, LLP | 11,637 | $55.6K |
| MetLife Investment Management | 9,710 | $46.4K |
| Northwestern Mutual Wealth Management Co | 5,295 | $25.3K |
| MAI Capital Management | 35 | $168 |
| Root Financial Partners, LLC | 28 | $134 |
| Wealth Preservation Advisors, LLC | 13 | $62 |
Not filed for Q2 2026 yet (3)
Institutions that held Foghorn Therapeutics Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Evelyn Partners Asset Management Ltd | 7,100 | $33.9K |
| CWM, LLC | 3,345 | $16.0K |
| Sunbelt Securities, Inc. | 1,000 | $4.78K |